Allopurinol use and risk of acute coronary syndrome in gout patients: a population-based cohort study in Sweden
In patients with gout and without CHD, long-term allopurinol use protects against first-ever ACS compared with non-users. In contrast, allopurinol initiators, possibly having more systemic inflammation, had a higher risk of first-ever ACS compared with long-term users.
Authors
- P. Drivelegka (ORCID: https://orcid.org/0000-0002-2349-8820)
- Tatiana Zverkova Sandström (ORCID: https://orcid.org/0000-0001-9478-2354)
- L. Jacobsson (ORCID: https://orcid.org/0000-0003-4402-148X)
- Mats Dehlin (ORCID: https://orcid.org/0000-0001-5165-0968)
- Ulf Lindström (ORCID: https://orcid.org/0000-0002-2250-9348)
- Karin Lövgren Bengtsson (ORCID: https://orcid.org/0000-0001-5154-0144)
Institutions
- Sahlgrenska University Hospital (SE)
- University of Gothenburg (SE)
Publication Details
- Journal
- BMJ Open
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1136/bmjopen-2024-092522
- Citations
- 4
- Primary Topic
- Gout, Hyperuricemia, Uric Acid
- Type
- article
- Field-Weighted Citation Impact
- 5.72
Funders
- Rune och Ulla Amlövs Stiftelse för Neurologisk och Reumatologisk Forskning
- Hjärt-Lungfonden
- Göteborgs Läkaresällskap
- Reumatikerförbundet